Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07648108

Evaluation of a Day Hospital Program for Adolescents and Young Adults With Eating Disorders

This study aims to evaluate the clinical, psychological, and functional outcomes of adolescents with anorexia nervosa receiving multidisciplinary care in hospital settings. Participants are treated either in a day hospitalization program or in a full-time inpatient program, in accordance with the French national guidelines (Haute Autorité de Santé, HAS) for the management of anorexia nervosa.

The study seeks to better understand the evolution of patients' health status over time, including nutritional, psychological, and social dimensions, and to identify factors associated with treatment response. Data will be collected as part of routine clinical care without modification of the standard therapeutic management.

The results of this study may help improve clinical practices and optimize care pathways for adolescents with anorexia nervosa.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adolescents and young adults aged 12 to 22 years
  • Diagnosed with an eating disorder
  • Referred for admission to the day hospital program between October 2019 and December 2023
  • Provided informed consent (and parental consent for minors)

Exclusion criteria

  • Refusal to participate
  • Age below 12 years or above 22 years

Treatment and study plan

Day Hospital Multidisciplinary Care

Other

Participants admitted to the day hospital receive a multidisciplinary treatment program including psychiatric, medical, nutritional, and psychosocial care, delivered through structured daytime sessions without overnight stay.

Standard Care Outside Day Hospital Program

Other

Participants not admitted to the day hospital program receive usual care according to standard clinical pathways outside the specialized day hospital setting.

Primary outcomes

  1. Change in Body Mass Index (BMI)

    Time frame: From admission request to at least 18 months follow-up

Secondary outcomes

  1. Change in eating disorder psychopathology assessed by EDE-Q

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

    Eating disorder psychopathology will be assessed using the Eating Disorder Examination Questionnaire (EDE-Q), a self-report scale ranging from 0 to 6, with higher scores indicating more severe symptoms. The assessment will be performed at admission and discharge.

  2. Change in body image concerns assessed by BSQ

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

    Body image concerns will be assessed using the Body Shape Questionnaire (BSQ), a self-report scale with higher scores indicating greater body dissatisfaction. The assessment will be performed at admission and discharge.

  3. Change in anxiety and depression symptoms assessed by HADS

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

    Anxiety and depression symptoms will be assessed using the Hospital Anxiety and Depression Scale (HADS), which includes subscales for anxiety and depression, each ranging from 0 to 21, with higher scores indicating greater symptom severity. The assessment will be performed at admission and discharge.

  4. Change in obsessive-compulsive symptoms assessed by MOCI

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

    Obsessive-compulsive symptoms will be assessed using the Maudsley Obsessive-Compulsive Inventory (MOCI), where higher scores indicate more severe symptoms. The assessment will be performed at admission and discharge.

  5. Change in eating disorder-related quality of life assessed by EDQoL

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

    Quality of life related to eating disorders will be assessed using the Eating Disorders Quality of Life (EDQoL) questionnaire, with higher scores indicating greater impairment. The assessment will be performed at admission and discharge

  6. Change in autistic traits assessed by AQ-10

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

    Autistic traits will be assessed using the Autism Spectrum Quotient (AQ-10), a brief screening tool with higher scores indicating more pronounced autistic traits. The assessment will be performed at admission and discharge

  7. Change in family functioning assessed by FAD-12

    Time frame: Baseline (at admission), discharge (end of hospitalization), and follow-up at least 18 months after admission

    Family functioning will be assessed using the Family Assessment Device (FAD-12), with higher scores indicating poorer family functioning. The assessment will be performed at admission and discharge.

Sponsors and collaborators

Lead sponsor

Fondation Santé des Étudiants de France

Other

Registry information

Official study title

Evaluation of the Contribution of a Specialized Day Hospital for Adolescents and Young Adults With Eating Disorders: Long-Term Clinical Outcomes and Cross-Reported Experiences

Acronym: UDJ-TCA

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jun 15, 2026
Registry last updated
Jun 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.